These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 7590703

  • 1. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.
    Sherman ME, Bur ME, Kurman RJ.
    Hum Pathol; 1995 Nov; 26(11):1268-74. PubMed ID: 7590703
    [Abstract] [Full Text] [Related]

  • 2. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF, Pizer ES, Ronnett BM, Kurman RJ.
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [Abstract] [Full Text] [Related]

  • 3. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.
    Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ.
    Hum Pathol; 1995 Nov; 26(11):1260-7. PubMed ID: 7590702
    [Abstract] [Full Text] [Related]

  • 4. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.
    Egan JA, Ionescu MC, Eapen E, Jones JG, Marshall DS.
    Int J Gynecol Pathol; 2004 Apr; 23(2):119-22. PubMed ID: 15084839
    [Abstract] [Full Text] [Related]

  • 6. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF, Kurman RJ.
    Verh Dtsch Ges Pathol; 1997 Apr; 81():228-32. PubMed ID: 9474874
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.
    Demopoulos RI, Mesia AF, Mittal K, Vamvakas E.
    Int J Gynecol Pathol; 1999 Jul; 18(3):233-7. PubMed ID: 12092593
    [Abstract] [Full Text] [Related]

  • 8. [Pathogenesis of endometrial cancer: clinicopathologic implications].
    Hui P.
    Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):705-7. PubMed ID: 17374250
    [No Abstract] [Full Text] [Related]

  • 9. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
    Lu B, Chen Q, Zhang X, Cheng L.
    Diagn Pathol; 2016 Jun 04; 11(1):46. PubMed ID: 27260518
    [Abstract] [Full Text] [Related]

  • 10. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE.
    Int J Surg Pathol; 2004 Jul 04; 12(3):207-23. PubMed ID: 15306933
    [Abstract] [Full Text] [Related]

  • 11. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
    Li C, Zota V, Woda BA, Rock KL, Fraire AE, Jiang Z, Lu D, Xu B, Dresser K, Lutman CV, Fischer AH.
    Mod Pathol; 2007 Dec 04; 20(12):1263-8. PubMed ID: 17885673
    [Abstract] [Full Text] [Related]

  • 12. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
    McCluggage WG, Connolly LE, McBride HA, Kalloger S, Gilks CB.
    Histopathology; 2012 Mar 04; 60(4):547-53. PubMed ID: 22250726
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA.
    Am J Surg Pathol; 2012 Dec 04; 36(12):1771-81. PubMed ID: 23154767
    [Abstract] [Full Text] [Related]

  • 14. Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas.
    Briese J, Schulte HM, Sajin M, Bamberger C, Redlin K, Milde-Langosch K, Löning T, Bamberger AM.
    Virchows Arch; 2008 Jul 04; 453(1):89-96. PubMed ID: 18415123
    [Abstract] [Full Text] [Related]

  • 15. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.
    Am J Surg Pathol; 2009 Oct 04; 33(10):1504-14. PubMed ID: 19623034
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.